...
首页> 外文期刊>Bioorganic and medicinal chemistry >Comparative molecular field analysis of fenoterol derivatives: A platform towards highly selective and effective beta(2)-adrenergic receptor agonists.
【24h】

Comparative molecular field analysis of fenoterol derivatives: A platform towards highly selective and effective beta(2)-adrenergic receptor agonists.

机译:FENoterol衍生物的比较分子场分析:高度选择性β(2) - 肾上腺素能受体激动剂的平台。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: To use a previously developed CoMFA model to design a series of new structures of high selectivity and efficacy towards the beta(2)-adrenergic receptor. RESULTS: Out of 21 computationally designed structures 6 compounds were synthesized and characterized for beta(2)-AR binding affinities, subtype selectivities and functional activities. CONCLUSION: the best compound is (R,R)-4-methoxy-1-naphthylfelnoterol with K(i)beta(2)-AR=0.28microm, K(i)beta(1)-AR/K(i)beta(2)-AR=573, EC(50cAMP)=3.9nm, EC(50cardio)=16nm. The CoMFA model appears to be an effective predictor of the cardiomocyte contractility of the studied compounds which are targeted for use in congestive heart failure.
机译:目的:使用先前开发的COMFA模型来设计一系列高选择性和效果的新结构,朝向β(2) - 肾上腺素能受体。 结果:在21个计算设计的结构中,合成了6种化合物,其特征在于β(2)-AR结合亲和力,亚型选择性和功能性。 结论:最佳化合物是(R,R)-4-甲氧基-1-萘酰齐甲醇醇,K(i)β(2) - = 0.28miCrom,K(I)β(1)-AR / K(I)β (2)-AR = 573,EC(50CAMP)= 3.9nm,EC(50cardio)= 16nm。 COMFA模型似乎是所研究的化合物的心肌细胞收缩性的有效预测因子,其靶向用于充血性心力衰竭。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号